Cite

    Ginger D. Constantine et al.. “Estradiol vaginal inserts (4 µg and 10 µg) for treating moderate to severe vulvar and vaginal atrophy: a review of phase 3 safety, efficacy and pharmacokinetic data.” Current medical research and opinion, vol. 34, 2018, pp. 2131–2136. http://access.bl.uk/ark:/81055/vdc_100072165030.0x000055